IMPORTANT SAFETY INFORMATION: Myrbetriq can increase blood pressure. Periodic blood pressure determinations are recommended, especially in hypertensive patients. Myrbetriq is not recommended for use in severe uncontrolled hypertensive patients (defined as systolic blood pressure ≥180 mm Hg and/or diastolic blood pressure ≥110 mm Hg).

Please see additional Important Safety Information below.

Are you and your patients
going round and round?

Take a step with
MYRBETRIQ® (mirabegron)

MYRBETRIQ is the first and only FDA-approved beta-3 adrenergic agonist.

*Subject to eligibility. Restrictions may apply.